ArticleCureus2025
Sodium-Glucose Co-transporter 2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis in a Recipient of Concurrent Pancreas-Kidney Transplantation With Type 1 Diabetes Mellitus.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Currently, sodium-glucose co-transporter 2 inhibitors (SGLT2is) are used frequently in a range of patients, including those with type 1 diabetes mellitus, raising concerns regarding the potential increased risk of SGLT2i-associated euglycemic diabetic ketoacidosis (EDKA). We report the case of a patient with type 1 diabetes who developed SGLT2i-associated EDKA during the perioperative period of concurrent pancreas and kidney transplantation procedure. A 41-year-old woman taking an SGLT2i underwent concurrent pancreas and kidney transplantation from a brain-dead donor. Acidosis was noted during surgery, which improved temporarily after the pancreas was transplanted. The pancreatic allograft was resected because of twisting of the anastomotic vessels, and acidosis recurred. The patient's blood glucose levels were consistently within the normal range. Blood ketone monitoring was initiated, and the patient was diagnosed with EDKA. Patients with type 1 diabetes taking SGLT2is who undergo emergency surgery are at risk of EDKA and should continually monitor their ketone levels.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.